Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2025 –2032 | |
|
|
USD 152.80 Million |
| USD 243.55 Million | |
| % | |
|
Global Minimally Invasive and Non-Invasive Product and Service Market Segmentation, By Product (Surgical Devices, Medical Robotics, Monitoring and Visualization Systems, Electrosurgical and Auxiliary Equipment, and Endosurgical Equipment), Surgery (Cosmetic, Gastrointestinal, Gynecological, Urological, Thoracic, Cardiac, Vascular and Orthopedic Surgeries), Technology (Non-Visual Imaging, Trans Catheter Surgery, and Laparoscopic Surgery), End-User (Hospital Surgical Departments, Surgery Centers, Individual Surgeons, Medical Schools, and Others)- Industry Trends and Forecast to 2032
Get Exclusive Sample Copy of this Report Here
|
Attributes
|
Minimally Invasive and Non-Invasive Product and Service Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players
|
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
|
Rising Integration of Robotics, AI, and Imaging Technologies
Driver
Growing Demand Due to Rising Chronic Diseases and Patient Preference for Safer Alternatives
Restraint/Challenge
High Equipment Costs and Regulatory Compliance Hurdles
The market is segmented on the basis of product, surgery, technology, and end-user
On the basis of product, the minimally invasive and non-invasive product and service market is segmented into surgical devices, medical robotics, monitoring and visualization systems, electrosurgical and auxiliary equipment, and endosurgical equipment. The surgical devices segment dominated the market with the largest revenue share of 43% in 2024, driven by their widespread application across multiple specialties including cardiology, gynecology, orthopedics, and urology. These devices form the foundation of minimally invasive procedures, offering improved precision, reduced trauma, and faster patient recovery times compared to traditional surgical methods. Growing adoption of laparoscopic instruments, catheters, and minimally invasive surgical kits is fueling demand across hospitals and surgical centers. The strong clinical evidence supporting better patient outcomes, coupled with reduced hospital stays and costs, positions surgical devices as the preferred choice among healthcare providers. The broad utility and continual product innovations in this category sustain its leading position in the global market.
The medical robotics segment is projected to witness the fastest growth during the forecast period, fueled by the rapid adoption of robotic-assisted surgery for its unparalleled precision, flexibility, and ability to perform complex procedures. Increasing investments by companies such as Intuitive Surgical, Medtronic, and Johnson & Johnson in next-generation robotic platforms are accelerating technological advancements. The segment is gaining momentum as hospitals adopt robotic solutions for cardiac, orthopedic, and gynecological surgeries, improving outcomes and reducing surgical fatigue. Integration with AI and advanced imaging further enhances robotic systems’ capabilities, making them increasingly attractive to both surgeons and patients. Rising demand for minimally invasive techniques in emerging economies and favorable reimbursement policies are expected to propel strong growth in this segment.
On the basis of surgery, the minimally invasive and non-invasive product and service market is segmented into cosmetic, gastrointestinal, gynecological, urological, thoracic, cardiac, vascular, and orthopedic surgeries. Gastrointestinal surgeries accounted for the largest market share in 2024, driven by the high prevalence of gastrointestinal disorders such as colorectal cancer, gallbladder disease, and gastrointestinal bleeding. Minimally invasive procedures such as laparoscopic cholecystectomy and colorectal surgery are increasingly being adopted due to shorter recovery times, reduced postoperative complications, and lower costs. Hospitals are prioritizing minimally invasive gastrointestinal procedures to improve patient turnover and reduce inpatient burdens. The growing use of endoscopic and laparoscopic tools has further enhanced precision and patient safety. Rising awareness of early disease detection and the availability of advanced technologies are contributing to the dominance of this segment.
Cardiac surgeries are expected to witness the fastest growth during the forecast period, driven by the increasing global burden of cardiovascular diseases and the rising adoption of minimally invasive techniques such as transcatheter aortic valve replacement (TAVR). These procedures significantly reduce recovery times and risks compared to open-heart surgeries, making them highly attractive to both patients and providers. The development of advanced imaging and catheter-based technologies has expanded the scope of minimally invasive cardiac interventions. With an aging population more vulnerable to heart conditions, demand for safer and less invasive treatments is accelerating. Partnerships between medical device companies and hospitals to expand access to minimally invasive cardiac care are expected to sustain robust growth in this segment.
On the basis of technology, the minimally invasive and non-invasive product and service market is segmented into non-visual imaging, transcatheter surgery, and laparoscopic surgery. Laparoscopic surgery held the largest market revenue share in 2024, owing to its widespread use in a variety of procedures including gynecological, gastrointestinal, and orthopedic surgeries. The technique is well-established in clinical practice, providing surgeons with enhanced visualization, precision, and control while minimizing patient trauma. The advantages of laparoscopic surgery—such as shorter hospital stays, faster recovery, and reduced complications—have made it the standard of care in many specialties. Continuous innovation in laparoscopic instruments and imaging technologies further strengthens the segment’s dominance. Strong patient preference for minimally invasive laparoscopic procedures and broad availability of skilled surgeons have reinforced its leadership in the global market.
The transcatheter surgery segment is anticipated to grow at the fastest CAGR during the forecast period, driven by the increasing popularity of catheter-based interventions such as TAVR, transcatheter mitral valve repair, and catheter-based vascular procedures. These techniques offer life-saving alternatives to patients who are not ideal candidates for open surgery due to age or comorbidities. Rising regulatory approvals and clinical trials validating the safety and efficacy of transcatheter procedures are fueling adoption worldwide. The strong pipeline of next-generation catheter-based devices, combined with supportive reimbursement frameworks, is accelerating market penetration. As healthcare providers increasingly prioritize less invasive cardiovascular solutions, the transcatheter surgery segment is expected to witness exceptional growth.
On the basis of end-user, the minimally invasive and non-invasive product and service market is segmented into hospital surgical departments, surgery centers, individual surgeons, medical schools, and others. Hospital surgical departments dominated the market in 2024, accounting for the largest revenue share due to their advanced infrastructure, availability of skilled surgeons, and ability to handle high patient volumes. Hospitals are often the primary facilities for complex minimally invasive and non-invasive procedures, supported by specialized operating rooms and advanced imaging technologies. The presence of strong reimbursement frameworks in developed markets further drives patient preference for hospital-based care. Increasing government and private investments in hospital infrastructure, coupled with continuous training and technology adoption, reinforce this segment’s leadership. The ability of hospitals to offer comprehensive care—from diagnosis to surgery and post-operative recovery—ensures their central role in the market.
Surgery centers are expected to record the fastest growth over the forecast period, fueled by the global shift toward outpatient and same-day procedures. Minimally invasive techniques require shorter recovery times, making them well-suited for ambulatory settings where cost-effectiveness and efficiency are prioritized. Patients increasingly prefer surgery centers for their convenience, reduced costs compared to hospitals, and shorter waiting times. Technological advancements are enabling surgery centers to perform a wider range of complex minimally invasive interventions. In addition, favorable regulatory support and insurance coverage for outpatient surgeries are accelerating adoption. The rise of specialized surgical centers focused on orthopedics, cardiology, and gastroenterology further supports the robust growth of this segment.
U.S. Minimally Invasive and Non-Invasive Product and Service Market Insight
The U.S. minimally invasive and non-invasive product and service market captured the largest revenue share of 82% in 2024 within North America, fueled by advanced healthcare infrastructure, high adoption of robotic-assisted surgery, and a strong focus on reducing hospital stays. Patients are increasingly opting for minimally invasive and non-invasive solutions due to faster recovery times and lower risks compared to open procedures. The growing integration of AI, robotics, and imaging in U.S. healthcare facilities is further accelerating market growth. Moreover, favorable reimbursement policies and continuous innovation by companies such as Medtronic, Boston Scientific, and Intuitive Surgical are driving significant adoption across hospitals and surgical centers.
Europe Minimally Invasive and Non-Invasive Product and Service Market Insight
The Europe minimally invasive and non-invasive product and service market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by rising demand for advanced treatment options, stringent healthcare regulations, and the growing burden of chronic diseases. Increasing urbanization, coupled with investments in healthcare infrastructure, is fostering adoption of minimally invasive and non-invasive technologies across both developed and emerging European markets. The region is experiencing notable uptake in gastrointestinal, cardiac, and orthopedic surgeries, with adoption supported by favorable government funding and collaborations between hospitals and medical device companies.
U.K. Minimally Invasive and Non-Invasive Product and Service Market Insight
The U.K. minimally invasive and non-invasive product and service market is anticipated to grow at a noteworthy CAGR during the forecast period, fueled by a strong emphasis on modernizing healthcare infrastructure and reducing surgical backlogs. Patients and healthcare providers are increasingly drawn to minimally invasive procedures for their safety, efficiency, and shorter recovery times. In addition, government initiatives promoting digital health and advanced surgical technologies are creating a favorable environment for adoption. With growing demand in both public NHS hospitals and private healthcare facilities, the U.K. is becoming an important hub for minimally invasive and non-invasive solutions.
Germany Minimally Invasive and Non-Invasive Product and Service Market Insight
The Germany minimally invasive and non-invasive product and service market is expected to expand at a considerable CAGR during the forecast period, supported by the country’s robust healthcare infrastructure, focus on innovation, and rising investments in robotic and imaging technologies. Germany’s preference for eco-conscious and precision-based medical solutions is fueling the demand for minimally invasive devices in both hospitals and specialized clinics. The integration of robotic platforms and advanced visualization systems into surgical workflows is becoming increasingly common. Furthermore, Germany’s strong manufacturing base and emphasis on high-quality medical technologies position it as a leader within the European market.
Asia-Pacific Minimally Invasive and Non-Invasive M Minimally Invasive and Non-Invasive Product and Service Market arket Insight
The Asia-Pacific minimally invasive and non-invasive product and service market is poised to grow at the fastest CAGR of 23% during the forecast period of 2025 to 2032, driven by rapid urbanization, rising disposable incomes, and expanding healthcare infrastructure in countries such as China, Japan, and India. Government initiatives promoting digitalization and smart healthcare are accelerating adoption of minimally invasive technologies. The region’s role as a key manufacturing hub for surgical devices and medical robotics is further driving affordability and accessibility. Growing medical tourism, particularly in countries such as India and Thailand, is also contributing to the rapid uptake of these advanced solutions.
Japan Minimally Invasive and Non-Invasive Product and Service Market Insight
The Japan minimally invasive and non-invasive product and service market is gaining momentum due to its strong culture of technological innovation, rapid urbanization, and a growing demand for efficient healthcare solutions. The adoption of minimally invasive and non-invasive procedures is driven by Japan’s aging population, which requires safer, quicker recovery solutions. Integration of robotic platforms, advanced imaging, and AI-driven diagnostics is fueling growth, as hospitals seek to improve precision and patient outcomes. Moreover, government support for healthcare modernization and the country’s well-established technology ecosystem are creating strong growth opportunities.
India Minimally Invasive and Non-Invasive Product and Service Market Insight
The India minimally invasive and non-invasive product and service market accounted for the largest market revenue share in Asia-Pacific in 2024, supported by the country’s expanding middle-class population, high demand for affordable healthcare, and rapid adoption of advanced medical technologies. India is emerging as a leading destination for medical tourism, with patients seeking cost-effective minimally invasive and non-invasive treatments. Government-led initiatives promoting smart cities and healthcare infrastructure upgrades are further driving adoption. In addition, the growing presence of domestic manufacturers and partnerships with global device companies are making advanced treatments more accessible, fueling strong market expansion across both urban and semi-urban regions.
The minimally invasive and non-invasive product and service industry is primarily led by well-established companies, including:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.